Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®)
- PMID: 22020697
- PMCID: PMC3259328
- DOI: 10.1007/s00405-011-1804-7
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®)
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
